Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod in Relapsing-Remitting Multiple Sclerosis
NCT00289978Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of fingolimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Novartis. Started Jan 2006; status: completed.
02
Drugs
fingolimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00289978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289978.